Medscape November 17, 2020
The COVID-19 pandemic has decimated the bottom lines of many private practices, prompting physician-owners to seriously contemplate selling.
Physician-owners have had to sell at lower prices, reflecting lower cash flow under COVID-19. But sales prices may rebound following news on November 9 that a COVID-19 vaccine candidate produced by Pfizer and its German partner, BioNTech, may be ready for initial distribution before the end of the year.
“There are a lot of if’s still, but if things go according to expectations, we may see an increase in the value of practices,” says Mark O. Dietrich, a CPA in Framingham, Massachusetts, who deals mostly with valuations of physician practices.
“Practice valuations have been lower because many patients have kept away and...
Today's Sponsors
Today's Sponsor